drugset / Trial / NCT07068932
A Clinical Study of SHR-4506 Injection in Patients With Malignant Tumors
NaSingle-groupOpen-labelTreatment
Summary
The study is being conducted to evaluate the safety and tolerability of SHR-4506 Injection in patients with malignant tumors and to determine the maximum tolerated dose (MTD) or maximum administered dose (MAD).
Timeline
- Start
- 2025-07-22
- Primary completion
- 2027-02
- Completion
- 2027-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHR-4506 | Unknown | — | — |
Indications
No indication recorded.